acute lymphoid leukemia
Showing 1 - 25 of 34
Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)
Recruiting
- Acute Lymphoid Leukemia
- +3 more
- Prednisone
- +9 more
-
São Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
Jul 24, 2023
H19 in Acute Lymphoblastic Leukemia.
Not yet recruiting
- Acute Lymphoid Leukemia
- (no location specified)
Jul 11, 2023
Acute Lymphoid Leukemia Trial in Seoul (Blincyto)
Not yet recruiting
- Acute Lymphoid Leukemia
-
Seoul, Gangnam-gu, Korea, Republic of
- +4 more
Apr 12, 2023
Acute Lymphoid Leukemia, Acute Myeloid Leukemia in Children Trial in Tours (Biological sampling in patients, Biological sampling
Not yet recruiting
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia in Children
- Biological sampling in patients
- Biological sampling in control patients
-
Tours, France
- +2 more
Mar 17, 2023
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (Orca-T,
Recruiting
- Acute Myeloid Leukemia
- +7 more
- Orca-T
- Standard-of-Care
-
Duarte, California
- +13 more
Jan 25, 2023
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma Trial in United States (Zilovertamab vedotin)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- +11 more
- Zilovertamab vedotin
-
Duarte, California
- +13 more
Jan 12, 2023
Acute Lymphoid Leukemia, Acute Lymphoblastic Leukemia Trial in Aurora (CD19 Directed CAR T Cell)
Not yet recruiting
- Acute Lymphoid Leukemia
- Acute Lymphoblastic Leukemia
- CD19 Directed CAR T Cell
-
Aurora, ColoradoUniversity of Colorado Hospital
Sep 12, 2022
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia Trial in Gainesville (Orca-Q)
Recruiting
- Acute Myeloid Leukemia
- +6 more
- Orca-Q
-
Gainesville, FloridaUniversity of Florida
Aug 26, 2022
Acute Lymphoid Leukemia, B-Cell Leukemia, Leukemia, Lymphocytic, B Cell Trial run by the National Cancer Institute (NCI)
Not yet recruiting
- Acute Lymphoid Leukemia
- +4 more
- fludarabine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 17, 2022
Acute Lymphoid Leukemia Trial in Philadelphia (huCART19)
Recruiting
- Acute Lymphoid Leukemia
- huCART19
-
Philadelphia, PennsylvaniaChildren's Hospital of Pennsylvania
Jul 21, 2022
Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia Trial in Moscow, Saint Petersburg
Recruiting
- Graft-versus-host-disease
- +3 more
- Ruxolitinib
- +2 more
-
Moscow, Russian Federation
- +1 more
Apr 4, 2022
Acute Lymphoid Leukemia Trial in Spain (ARI-0001 cells)
Recruiting
- Acute Lymphoid Leukemia
- ARI-0001 cells
-
Badalona, Barcelona, Spain
- +9 more
Feb 3, 2022
Latin American Real-world Study in Acute Leukemia
Recruiting
- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
-
Montería, ColombiaOncomedica SA
Jan 5, 2022
Acute Lymphoid Leukemia Trial in Italy (Inotuzumab Ozogamicin (IO))
Recruiting
- Acute Lymphoid Leukemia
- Inotuzumab Ozogamicin (IO)
-
Ancona, Italy
- +29 more
Dec 31, 2021
Acute Lymphoid Leukemia, Philadelphia Chromosome-Negative B-Cell Precursor Trial in Italy (Chemotherapy + Blinatumomab)
Active, not recruiting
- Acute Lymphoid Leukemia
- Philadelphia Chromosome-Negative B-Cell Precursor
- Chemotherapy + Blinatumomab
-
Ancona, Italy
- +61 more
Jan 3, 2022
Muscle Dysfunction in Patients With Haematological Diseases
Recruiting
- Hematologic Diseases
- +4 more
-
Copenhagen, DenmarkRigshospitalet
Dec 3, 2021
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in United States (TregGraft (Orca-T))
Recruiting
- Acute Myeloid Leukemia
- +4 more
- TregGraft (Orca-T)
-
Duarte, California
- +13 more
Oct 28, 2021
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)
Withdrawn
- Acute Myeloid Leukemia
- +7 more
- MDG1021 dose 1
- +3 more
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Centre
Sep 30, 2021
Acute Myeloid Leukemia, Acute Lymphoid Leukemia Trial in Mexico City (Busulfan, Cyclophosphamide, CXCR4 Antagonist)
Unknown status
- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
- Busulfan
- +3 more
-
Mexico City, Distrito Federal, MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myeloproliferative Disorders Trial in Perugia (High dose irradiation
Recruiting
- Acute Myeloid Leukemia
- +5 more
- High dose irradiation conditioning + Treg/Tcon
-
Perugia, PG, ItalyUniversity of Perugia
Jan 8, 2020
MDS, Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Gainesville (Molecular diagnostic testing)
Terminated
- Myelodysplastic Syndromes
- +6 more
- Molecular diagnostic testing
-
Gainesville, FloridaUF Health Shands Cancer Hospital
Dec 18, 2019
Muscle Dysfunction in Hematological Diseases Referred to Stem
Not yet recruiting
- Hematologic Diseases
- +7 more
- No intervention
-
Copenhagen, DenmarkRigshospitalet
Nov 15, 2019
Chemotherapy-related Cognitive Impairment and Recovery
Completed
- Myelodysplastic Syndrome
- +8 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Jul 26, 2019
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Hematopoetic Myelodysplasia Trial in Indianapolis, Valhalla (Sitagliptin)
Completed
- Acute Myeloid Leukemia
- +4 more
-
Indianapolis, Indiana
- +1 more
Dec 17, 2018
Acute Lymphoid Leukemia Trial in Pusan, Seoul (alloHCT)
Terminated
- Acute Lymphoid Leukemia
- alloHCT
-
Pusan, Korea, Republic of
- +1 more
Jul 19, 2018